Asia · General news · The Hindu
Are lower MRPs on cancer drugs translating into affordable care?
National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, reducing the price of nearly 900 cancer medicine brands…
Read the full article on The Hindu Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thehindu.com)


